The dystrophin lymphocyte promoter revisited: 4.5-Megabase intron, or artefact?

Neuromuscular Disorders

Volumn 13, Issue 1, 2003, Pages 17-20

  Wheway, Joanna M ^a   Roberts, Roland G ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

Chronic granulomatous disease; Duchenne muscular dystrophy; Dystrophin; Promoters

Indexed keywords

DYSTROPHIN;

ARTICLE; ARTIFACT; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CYBB GENE; DUCHENNE MUSCULAR DYSTROPHY; EVALUATION; EXON; GENE; GENE ACTIVITY; GENE MAPPING; GENE SEQUENCE; GENETIC LINKAGE; HUMAN; HUMAN CELL; INTRON; LYMPHOCYTE; MALE; MUSCLE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; SPECIES DIFFERENCE; TISSUE;

ANIMALS; ARTIFACTS; CHROMOSOMES, HUMAN, X; DYSTROPHIN; EXONS; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INTRONS; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; PROMOTER REGIONS (GENETICS); REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA SPLICING; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION, GENETIC;

EID: 0037211541     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(02)00195-5     Document Type: Article

References (12)

1. Nishio H., Takeshima Y., Narita N., et al. Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J Clin Invest. 94:1994;1037-1042.
2. Sarkar G., Sommer S.S. Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science. 244:1989;331-334.
3. Chelly J., Concordet J.P., Kaplan J.C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci USA. 86:1989;2617-2621.
4. Chelly J., Kaplan J.C., Maire P., Gautron S., Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature. 333:1988;858-860.
5. Roberts R.G., Bobrow M., Bentley D.R. Point mutations in the dystrophin gene. Proc Natl Acad Sci USA. 89:1992;2331-2335.
6. Gardner R.J., Bobrow M., Roberts R.G. The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet. 57:1995;311-320.
7. Royer-Pokora B., Kunkel L.M., Monaco A.P., et al. Cloning the gene for an inherited human disorder - chronic granulomatous disease - on the basis of its chromosomal location. Nature. 322:1986;32-38.
8. Su A.I., Cooke M.P., Ching K.A., et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA. 99:2002;4465-4470.
9. McCabe E.R., Towbin J.A., van den Engh G., Trask B.J. Xp21 contiguous gene syndromes: deletion quantitation with bivariate flow karyotyping allows mapping of patient breakpoints. Am J Hum Genet. 51:1992;1277-1285.
10. Tennyson C.N., Klamut H.J., Worton R.G. The human dystrophin gene requires 16 h to be transcribed and is cotranscriptionally spliced. Nat Genet. 9:1995;184-190.
11. Christophe-Hobertus C., Szpirer C., Guyon R., Christophe D. Identification of the gene encoding brain cell membrane protein 1 (BCMP1), a putative four-transmembrane protein distantly related to the peripheral myelin protein 22/epithelial membrane proteins and the claudins. BMC Genomics. 2:2001;3.
12. Hentze M.W., Kulozik A.E. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 96:1999;307-310.